IPP Bureau
Health Minister Mandaviya inaugurates the phase II of Mass Drug Administration initiative for Lymphatic Filariasis
By IPP Bureau - August 12, 2023
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
Govt. of Arunachal, Sir Ganga Ram Hospital and Religare Enterprises sign an MoU to support the development of the state’s healthcare services
By IPP Bureau - August 12, 2023
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
DuPont to commercialize pharma silicone tubing ‘Liveo’ produced in China
By IPP Bureau - August 12, 2023
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
Dimensionless Technologies launches AushadhAI to support pharma supply chain
By IPP Bureau - August 12, 2023
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
India is set to become the global hub of medical technology and devices: Dr Mandaviya
By IPP Bureau - August 11, 2023
The medical device sector is considered as one of the sunrise sectors in the country
SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr
By IPP Bureau - August 10, 2023
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Granules India posts Q1 FY24 revenue from operations at Rs. 985.5 Cr
By IPP Bureau - August 10, 2023
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr
By IPP Bureau - August 10, 2023
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr
By IPP Bureau - August 10, 2023
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr
By IPP Bureau - August 10, 2023
Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023
Abbott India's Q1 FY24 PAT up at Rs. 290.24 Cr
By IPP Bureau - August 10, 2023
Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023
IOL Chemicals and Pharmaceuticals posts Q1 FY24 consolidated PAT at Rs. 45.86 Cr
By IPP Bureau - August 10, 2023
IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023
Dishman Carbogen Amcis posts Q1 FY24 consolidated PAT at Rs. 17 Cr
By IPP Bureau - August 10, 2023
Dishman Carbogen Amcis has reported total income of Rs. 729.91 crores during the period ended June 30, 2023
Lincoln Pharmaceuticals posts Q1 FY24 standalone net profit at Rs. 19.01 Cr
By IPP Bureau - August 10, 2023
DKSH and Biolin Scientific extend partnership in the APAC region
By IPP Bureau - August 09, 2023
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
